Fig. 2: Outcomes based on MRD response.

a Overall Survival (OS) in measurable residual disease (MRD)-negative vs MRD-positive patients. b Disease-free survival (DFS) in MRD-negative vs MRD-positive patients. c Cumulative Incidence of Relapse (CIR) in MRD-negative vs MRD-positive patients.